Knudsen T
Department of Pharmacology, University of Odense.
Dan Med Bull. 1995 Nov;42(5):441-54.
The mast cell contains potent mediators of inflammation which are released after IgE-directed and non-IgE-directed stimulation of the cell. This highly specialized cell is therefore ascribed a role in the pathogenesis of disease states in which the inflammatory response plays a role for the development of the clinical symptoms. Thus, besides being of interest in basic research, studies of the cellular processes leading to release of inflammatory mediators from the mast cell also have important clinical implications. The aim of the present work has been to document the existence of the Na+/K(+)-pump in rat peritoneal mast cells, to investigate the regulation of the pump activity and to explore whether modulation of the pump activity interferes with the cellular stimulus/secretion coupling mechanism. The Na+/K(+)-pump activity following stimulation of the mast cell was also investigated. The pump activity was assessed as the ouabain-sensitive cellular potassium uptake with 86Rb+ as a tracer for potassium. The histamine release from the mast cell following IgE-directed and non-IgE directed stimulation of the cell was used as a parameter for cellular degranulation. Histamine was measured by spectrofluorometry. The finding of an ouabain-sensitive uptake mechanism in the mast cell documents the presence of a functional Na+/K(+)-pump in this cell. The pump activity is inhibited by lanthanides and by the divalent cations calcium, magnesium, barium and strontium. The pump has a large reserve capacity which probably is caused by a low intracellular concentration of sodium. This enables the pump to respond to changes in the intracellular sodium concentration. The inhibitory effect of di- and trivalent ions on the pump activity is probably a result of the inhibitory effect of these ions on the cellular sodium uptake. The digitalis glycosides, ouabain and digoxin, but not the more lipophilic drug digitoxigenin, increase both IgE-directed and non-IgE-directed histamine release from the mast cell in a calcium-free medium, while there is no effect of digitalis glycosides in a medium containing physiologically relevant concentrations of calcium. The effect of digitalis glycosides on the histamine release is dependent on the drug concentrations used and the time of preincubation. An increase in the intracellular concentration of sodium secondary to inhibition of the Na+/K(+)-pump is the effector mechanism likely to explain the effect of digitalis glycosides on the mast cell histamine release. Increases in intracellular sodium might affect the intracellular concentration of calcium via changes in Na+/Ca(2+)-exchange. IgE-directed and non-IgE-directed stimulation of the mast cell activates the Na+/K(+)-pump. In case of compound 48/80-induced histamine release, the pump is stimulated for at least 2 hr. It is proposed, that the poststimulatory activation of the Na+/K(+)-pump is due to increased cellular sodium uptake associated with the release process. This sodium uptake may occur via Na+/Ca(2+)-exchange, Na+/H(+)-exchange, Na+/K+/2Cl(-)-cotransport or a non-selective ion channel. Besides describing aspects of the function and regulation of the Na+/K(+)-pump in the rat peritoneal mast cells, this thesis points to the potential role of sodium transport mechanisms in mast cell physiology. Pharmacological manipulations of such transport mechanisms might in the future add to the treatment of allergic diseases.
肥大细胞含有强效炎症介质,在细胞受到IgE介导和非IgE介导的刺激后释放。因此,这种高度特化的细胞在疾病状态的发病机制中被认为发挥了作用,在这些疾病状态中,炎症反应对临床症状的发展起到了作用。因此,除了在基础研究中具有重要意义外,对导致肥大细胞释放炎症介质的细胞过程的研究也具有重要的临床意义。本研究的目的是证实大鼠腹膜肥大细胞中存在Na+/K(+)-泵,研究该泵活性的调节,并探讨泵活性的调节是否会干扰细胞刺激/分泌偶联机制。还研究了肥大细胞受刺激后的Na+/K(+)-泵活性。泵活性通过以86Rb+作为钾的示踪剂来评估哇巴因敏感的细胞钾摄取。肥大细胞在受到IgE介导和非IgE介导的刺激后组胺释放用作细胞脱颗粒的参数。组胺通过荧光分光光度法测定。在肥大细胞中发现哇巴因敏感的摄取机制证明了该细胞中存在功能性Na+/K(+)-泵。泵活性受到镧系元素以及二价阳离子钙、镁、钡和锶的抑制。该泵具有很大的储备能力,这可能是由于细胞内钠浓度较低所致。这使得泵能够对细胞内钠浓度的变化做出反应。二价和三价离子对泵活性的抑制作用可能是这些离子对细胞钠摄取的抑制作用的结果。洋地黄糖苷哇巴因和地高辛,但不是亲脂性更强的药物洋地黄毒苷,在无钙培养基中增加了肥大细胞中IgE介导和非IgE介导的组胺释放,而在含有生理相关浓度钙的培养基中洋地黄糖苷没有作用。洋地黄糖苷对组胺释放的影响取决于所用药物浓度和预孵育时间。抑制Na+/K(+)-泵继发的细胞内钠浓度增加是可能解释洋地黄糖苷对肥大细胞组胺释放作用的效应机制。细胞内钠的增加可能通过Na+/Ca(2+)-交换的变化影响细胞内钙浓度。肥大细胞受到IgE介导和非IgE介导的刺激会激活Na+/K(+)-泵。在化合物48/80诱导组胺释放的情况下,该泵至少被刺激2小时。有人提出,刺激后Na+/K(+)-泵的激活是由于与释放过程相关的细胞钠摄取增加。这种钠摄取可能通过Na+/Ca(2+)-交换、Na+/H(+)-交换、Na+/K+/2Cl(-)-共转运或非选择性离子通道发生。除了描述大鼠腹膜肥大细胞中Na+/K(+)-泵的功能和调节方面外,本论文还指出了钠转运机制在肥大细胞生理学中的潜在作用。对这种转运机制的药理学操作未来可能会增加对过敏性疾病的治疗。